Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Director/PDMR Shareholding

3 Dec 2008 11:59

RNS Number : 4632J
ABCAM Plc
03 December 2008
 



For immediate release

3 December 2008

ABCAM PLC

("Abcam" or "the Company")

ABCAM PLC SHARE INCENTIVE PLAN 

Directors' Dealings

On 7 November 2008 Abcam announced that as a result of transactions on 6 November 2008 by the Abcam plc Share Incentive Plan -"the Plan" - (an HMRC approved all employee share purchase plan adopted by the Company's shareholders at the Company's AGM on 3 November 2008), Jonathan Milner, Jeff Iliffe and Jim Warwick, Executive Directors of the Company, had each been awarded 649 "Free shares". The beneficial ownership of these shares will pass to the Executive Directors on 6 November 2011 subject to their continued employment with Abcam plc.

The final dividend of 4.56 pence per share which was approved at the AGM was paid on 28 November 2008. Pursuant to the terms of the Plan, on 2 December 2008, the dividend paid on the "Free shares" granted to the Executive Directors as detailed above was used to purchase additional shares at 475p each to be held on behalf of the Executive Directors in the Abcam plc Share Incentive Plan. These shares are as detailed below: 

Dividend shares  purchased

No of shares held in the

Plan on 2 December 2008

Including the dividend

shares

Jeff Iliffe

6

1,273

Jonathan Milner

6

1,273

Jim Warwick

6

1,273

For further information please contact:

Abcam
+ 44 (0) 1223 696000
Jonathan Milner, Chief Executive Officer
 
Jeff Iliffe, Chief Financial Officer
www.abcam.com
 
 
 
Numis Securities
+ 44 (0) 20 7776 1500
Nominated Adviser - Michael Meade, Nick Westlake
Corporate Broking - James Black
 
 
 
Buchanan Communications
+ 44 (0) 20 7466 5000
Mark Court / Mary-Jane Johnson
 
 
 

Notes for editors:

About Abcam plc

Abcam is a producer and distributor of research-grade antibodies headquartered in CambridgeUK, with a US office located in CambridgeMassachusetts and a Japanese office in Tokyo. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world with product information provided and ordering available through the Company's website, www.abcam.com. The antibodies are sold under the Abcam brand name. The Company's vision is to build the largest online antibody resource in the world while also ensuring that the antibodies are of high quality and commercially viable. Abcam now has an online catalogue of over 47,000 products, most of which are antibodies, from over 250 suppliers supported by up-to-date and detailed technical data sheets, which are created by the Company. The Company currently employs over 200 staff in its three operating companies.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFXLFBVLBEFBZ
Date   Source Headline
9th Dec 20162:56 pmRNSDirector/PDMR Shareholding
8th Dec 20165:09 pmRNSDirector/PDMR Shareholding
5th Dec 20162:45 pmRNSDirector/PDMR Shareholding
1st Dec 20164:01 pmRNSTotal Voting Rights
10th Nov 20162:00 pmRNSApplication for admission to trading
10th Nov 20167:00 amRNSAxioMx technology milestones accelerated
7th Nov 201611:21 amRNSDirector/PDMR Shareholding
7th Nov 20169:30 amRNSDirector/PDMR Shareholding
2nd Nov 20164:22 pmRNSResult of AGM
2nd Nov 20167:00 amRNSAGM Statement
1st Nov 20163:02 pmRNSTotal Voting Rights
27th Oct 20167:00 amRNSDirector/PDMR Shareholding
24th Oct 20167:00 amRNSNew facility at Cambridge Biomedical Campus
3rd Oct 20161:07 pmRNSTotal Voting Rights
3rd Oct 20167:00 amRNSDirector/PDMR Shareholding
28th Sep 20168:43 amRNSDirector/PDMR Shareholding
26th Sep 20167:19 amRNSAnnual Financial Report
21st Sep 20167:00 amRNSDirector/PDMR Shareholding
21st Sep 20167:00 amRNSHolding(s) in Company
15th Sep 20162:25 pmRNSDirector/PDMR Shareholding
12th Sep 20167:00 amRNSPreliminary Results
2nd Sep 20167:00 amRNSApplication for admission to trading
24th Aug 20167:00 amRNSNotice of Results
23rd Aug 20163:01 pmRNSBlock listing Interim Review
3rd Aug 20167:00 amRNSDirectorate Change
1st Aug 20161:11 pmRNSTotal Voting Rights
25th Jul 20167:00 amRNSPre-Close Period Update
1st Jul 20162:12 pmRNSTotal Voting Rights
20th Jun 20167:00 amRNSAbcam to appoint Gavin Wood as CFO
1st Jun 20164:38 pmRNSTotal Voting Rights
3rd May 20162:03 pmRNSTotal Voting Rights
19th Apr 20162:35 pmRNSDirector/PDMR Shareholding
1st Apr 20161:50 pmRNSTotal Voting Rights
24th Mar 20162:29 pmRNSDirector/PDMR Shareholding
24th Mar 20167:00 amRNSPosting of Half Yearly Report
22nd Mar 20169:33 amRNSDirector/PDMR Shareholding
7th Mar 20167:00 amRNSDirectorate Change
7th Mar 20167:00 amRNSHalf Yearly Report
10th Feb 201610:59 amRNSNotice of Results
8th Feb 20163:58 pmRNSBlocklisting Interim Review
1st Feb 20162:06 pmRNSTotal Voting Rights
29th Jan 20163:09 pmRNSHolding(s) in Company
25th Jan 20167:00 amRNSHalf Year Trading Update
4th Jan 20163:02 pmRNSTotal Voting Rights
7th Dec 20153:57 pmRNSDirector/PDMR Shareholding
7th Dec 20151:59 pmRNSDirector/PDMR Shareholding
1st Dec 20154:30 pmRNSTotal Voting Rights
12th Nov 20153:22 pmRNSApplication for admission to trading - update
12th Nov 20152:56 pmRNSDirector/PDMR Shareholding
11th Nov 20154:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.